| Cover | May 14, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Amendment No. 1 on Form 8-K/A (this “Amendment No. 1”) is being filed by Allarity Therapeutics, Inc. (the “Company”) to amend the Current Report on Form 8-K filed on May 15, 2024 (the “Original Report”), solely to include certain information under Item 8.01. Except as provided herein, the disclosures made in the Original Report remain unchanged. |
| Document Period End Date | May 14, 2024 |
| Entity File Number | 001-41160 |
| Entity Registrant Name | ALLARITY THERAPEUTICS, INC. |
| Entity Central Index Key | 0001860657 |
| Entity Tax Identification Number | 87-2147982 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 24 School Street |
| Entity Address, Address Line Two | 2nd Floor |
| Entity Address, City or Town | Boston |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02108 |
| City Area Code | 401 |
| Local Phone Number | 426-4664 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | ALLR |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
